SABBY MANAGEMENT, LLC - Q3 2020 holdings

$670 Million is the total value of SABBY MANAGEMENT, LLC's 132 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 94.2% .

 Value Shares↓ Weighting
BuyBIOGEN INCcall$95,146,000
+97.1%
3,354
+85.9%
14.20%
+46.6%
SellBIOGEN INCput$66,920,000
-1.7%
2,359
-7.3%
9.99%
-26.9%
 SELECT SECTOR SPDR TRput$48,879,000
+5.4%
4,6340.0%7.30%
-21.6%
NewTESLA INCcall$36,466,000850
+100.0%
5.44%
BuyISHARES RUSSELL 2000put$32,774,000
+20.4%
2,188
+15.1%
4.89%
-10.5%
BuySPDR S&P 500put$31,178,000
+65.8%
931
+52.6%
4.65%
+23.3%
BuyMODERNA INCput$29,517,000
+57.7%
4,172
+43.1%
4.41%
+17.3%
BuySPDR S&P 500call$29,035,000
+67.8%
867
+54.5%
4.34%
+24.9%
NewTESLA INCput$21,402,000435
+100.0%
3.20%
BuyASTRAZENECA PLCput$16,851,000
+372.0%
3,075
+355.6%
2.52%
+250.9%
 ISHARES RUSSELL 2000call$15,728,000
+4.6%
1,0500.0%2.35%
-22.2%
SellSPDR SERIES TRUSTput$14,898,000
-42.5%
1,337
-42.2%
2.22%
-57.2%
BIIB SellBIOGEN INC$12,634,000
-54.6%
44,536
-57.1%
1.89%
-66.2%
SellISHARES NASDAQ BIOTECHput$12,498,000
-13.2%
923
-12.3%
1.87%
-35.4%
BuyCEL-SCI CORPput$9,911,000
+115.4%
7,773
+152.0%
1.48%
+60.2%
BuySELECT SECTOR SPDR TRcall$8,797,000
+32.0%
834
+25.2%
1.31%
-1.9%
MRNA BuyMODERNA INC$8,630,000
+87.0%
121,975
+69.7%
1.29%
+38.9%
AZN BuyASTRAZENECA PLCadr$8,107,000
+389.3%
147,945
+372.4%
1.21%
+263.4%
SellSORRENTO THERAPEUTICSput$7,964,000
+25.8%
7,143
-29.1%
1.19%
-6.5%
BuyMODERNA INCcall$7,726,000
+661.2%
1,092
+591.1%
1.15%
+465.2%
SellBRAINSTORM CELL THERAPEUTICSput$7,519,000
-77.3%
4,444
-52.4%
1.12%
-83.2%
SRNE NewSORRENTO THERAPEUTICS$6,760,000606,298
+100.0%
1.01%
NewPFIZER INCcall$6,668,0001,817
+100.0%
1.00%
SellPLURISTEM THERAPEUTICSput$6,301,000
+16.1%
5,984
-2.5%
0.94%
-13.6%
BuyCEL-SCI CORPcall$5,871,000
+100.9%
4,605
+135.1%
0.88%
+49.2%
BuyFIBROGEN INCput$5,831,000
+2.2%
1,418
+0.8%
0.87%
-24.0%
NewCARDIFF ONCOLOGYput$5,516,0003,887
+100.0%
0.82%
NewBARCLAYS BANK PLCcall$4,920,0001,976
+100.0%
0.73%
IMMU NewIMMUNOMEDICS INC$4,252,00050,000
+100.0%
0.64%
ACAD NewACADIA PHARMACEUTICALS INC$4,122,00099,921
+100.0%
0.62%
SellAVEO PHARMACEUTICALS INCput$4,040,000
+7.4%
6,801
-6.9%
0.60%
-20.1%
RMTI NewROCKWELL MEDICAL INC$3,847,0003,595,415
+100.0%
0.57%
NewSPI ENERGY CO LTD$3,065,000425,762
+100.0%
0.46%
ITCI NewINTRA-CELLULAR THERAPIES$2,951,000115,000
+100.0%
0.44%
NewASTRAZENECA PLCcall$2,855,000521
+100.0%
0.43%
BuyINOVIO PHARMACEUTICALSput$2,814,000
-51.7%
2,426
+12.3%
0.42%
-64.0%
CIDM NewCINEDIGM CORP$2,755,0004,875,949
+100.0%
0.41%
SellTRILLIUM THERAPEUTICS INCcall$2,643,000
+43.6%
1,860
-18.2%
0.40%
+7.0%
 ISHARES NASDAQ BIOTECHcall$2,559,000
-0.9%
1890.0%0.38%
-26.3%
CKPT NewCHECKPOINT THERAPEUTICS$2,496,000931,240
+100.0%
0.37%
VXX NewBARCLAYS BANK PLCetf$2,490,000100,000
+100.0%
0.37%
COCP NewCOCRYSTAL PHARMA INC$2,480,0002,667,293
+100.0%
0.37%
SHIP NewSEANERGY MARITIME$2,443,0005,349,284
+100.0%
0.36%
XSPA NewXPRESSPA GROUP INC$2,347,0001,191,233
+100.0%
0.35%
NMRD NewNEMAURA MEDICAL INC$2,179,000613,765
+100.0%
0.32%
NVCN BuyNEOVASC INC$2,160,000
+178.4%
1,009,406
+209.6%
0.32%
+106.4%
PULM BuyPULMATRIX INC$2,071,000
+9761.9%
1,740,663
+14473.5%
0.31%
+7625.0%
BuyCELLDEX THERAPEUTICcall$2,064,000
+102.9%
1,392
+78.0%
0.31%
+51.0%
PRFX NewPAINREFORM LTD$2,047,000444,941
+100.0%
0.31%
BuyIONIS PHARMACEUTICALScall$2,031,000
+177.8%
428
+245.2%
0.30%
+106.1%
BLU NewBELLUS HEALTH INC NEW$1,999,000880,400
+100.0%
0.30%
DXR NewDAXOR CORP$1,928,000122,406
+100.0%
0.29%
EYEN NewEYENOVIA INC$1,899,000608,720
+100.0%
0.28%
CNTG NewCENTOGENE N V$1,724,000182,275
+100.0%
0.26%
IBB BuyISHARES NASDAQ BIOTECHetf$1,540,000
+23.4%
11,372
+24.6%
0.23%
-8.4%
AFIB NewACUTUS MEDICAL INC$1,480,00049,656
+100.0%
0.22%
INO BuyINOVIO PHARMACEUTICALS$1,449,000
+2583.3%
124,884
+6144.2%
0.22%
+1863.6%
CRIS SellCURIS INC$1,380,000
-49.7%
1,179,600
-48.0%
0.21%
-62.6%
CVM BuyCEL-SCI CORP$1,375,000
+4.2%
107,878
+22.0%
0.20%
-22.6%
FGEN SellFIBROGEN INC$1,219,000
-10.4%
29,654
-11.6%
0.18%
-33.3%
OLB NewOLB GROUP INC$1,166,000311,010
+100.0%
0.17%
SPCB NewSUPERCOM LTD$1,125,0001,480,000
+100.0%
0.17%
NewSAREPTA THERAPEUTICput$1,067,00076
+100.0%
0.16%
ODT BuyODONATE THERAPEUTICS INC$1,051,000
-38.7%
78,278
+93.3%
0.16%
-54.4%
BuyAURINIA PHARMACEUTICALScall$1,037,000
+128.9%
704
+152.3%
0.16%
+70.3%
NRBO SellNEUROBO PHARMACEUTICALS$1,026,000
-45.2%
182,543
-21.5%
0.15%
-59.3%
SellALTIMMUNE INCput$1,005,000
-67.2%
761
-73.4%
0.15%
-75.6%
BuyIONIS PHARMACEUTICALSput$1,006,000
+1.5%
212
+26.2%
0.15%
-24.6%
PDSB NewPDS BIOTECHNOLOGY CORP$978,000419,836
+100.0%
0.15%
BuySPDR GOLD TRUSTcall$826,000
-88.7%
2,262
+418.8%
0.12%
-91.6%
TTNP NewTITAN PHARMACEUTICALS$803,0004,856,723
+100.0%
0.12%
RKDA BuyARCADIA BIOSCIENCES INC$770,000
+243.8%
275,123
+362.1%
0.12%
+155.6%
GOVX NewGEOVAX LABS INC$768,000240,654
+100.0%
0.12%
GNCA BuyGENOCEA BIOSCIENCES INC$716,000
+148.6%
312,666
+149.5%
0.11%
+84.5%
NewEVOKE PHARMA INCput$712,0001,519
+100.0%
0.11%
NewAKERS BIOSCIENCES INC$675,000299,913
+100.0%
0.10%
BBI NewBRICKELL BIOTECH INC$652,000721,887
+100.0%
0.10%
NewAMARIN CORP PLCcall$643,0005,083
+100.0%
0.10%
EMBI NewEMERALD BIOSCIENCE INC$633,00014,936,716
+100.0%
0.09%
PSTI BuyPLURISTEM THERAPEUTICS$629,000
+139.2%
59,730
+101.1%
0.09%
+77.4%
LPCN BuyLIPOCINE INC NEW$625,000
+3372.2%
443,469
+2968.6%
0.09%
+2225.0%
NewSAREPTA THERAPEUTICcall$618,00044
+100.0%
0.09%
BuyCATABASIS PHARMSput$552,000
+80.4%
891
+87.2%
0.08%
+34.4%
BuyPOLARITYTE INCput$501,000
+1904.0%
4,816
+2308.0%
0.08%
+1400.0%
BuyXPRESSPA GROUP INCput$497,000
+252.5%
2,522
+648.4%
0.07%
+164.3%
SellODONATE THERAPEUTICS INCput$475,000
-76.4%
354
-25.5%
0.07%
-82.4%
CYCC NewCYCLACEL PHARMACEUTICALS$458,000125,578
+100.0%
0.07%
NewCARDIFF ONCOLOGYcall$450,000317
+100.0%
0.07%
ADTX NewADITX THERAPEUTICS INC$439,000224,971
+100.0%
0.07%
XLV SellSELECT SECTOR SPDR TRetf$422,000
-96.0%
4,000
-96.2%
0.06%
-97.0%
PAVMZ SellPAVMED INC*w$364,000
-58.0%
436,973
-48.1%
0.05%
-69.0%
 CYTOKINETICS INCcall$340,000
-8.1%
1570.0%0.05%
-31.1%
USEG NewU S ENERGY CORP WY$333,00066,504
+100.0%
0.05%
SCPH SellSCPHARMACEUTICALS INC$316,000
-65.9%
42,407
-66.3%
0.05%
-74.7%
NewCALADRIUS BIOSCIENCESput$293,0001,630
+100.0%
0.04%
MKGI NewMONAKER GROUP INC$297,000134,585
+100.0%
0.04%
PHAS BuyPHASEBIO PHARMACEUTICALS$279,000
-21.2%
79,470
+3.2%
0.04%
-40.8%
SellGENOCEA BIOSCIENCES INCcall$236,000
-51.7%
1,032
-51.5%
0.04%
-64.3%
SNCA BuySENECA BIOPHARMA INC$229,000
+175.9%
393,411
+242.1%
0.03%
+100.0%
AUPH SellAURINIA PHARMACEUTICALS$200,000
-50.7%
13,544
-45.8%
0.03%
-63.0%
NewHEPION PHARMACEUTICALSput$184,000591
+100.0%
0.03%
ALT NewALTIMMUNE INC$182,00013,800
+100.0%
0.03%
HEPA NewHEPION PHARMACEUTICALS$178,00057,309
+100.0%
0.03%
CLBS NewCALADRIUS BIOSCIENCES$173,00096,001
+100.0%
0.03%
BuyCATABASIS PHARMScall$171,000
+163.1%
277
+174.3%
0.03%
+100.0%
GOVXW NewGEOVAX LABS INC*w$169,000191,657
+100.0%
0.02%
NewACTINIUM PHARMACEUTICALSput$159,000164
+100.0%
0.02%
AVEO SellAVEO PHARMACEUTICALS INC$155,000
-65.6%
26,039
-70.2%
0.02%
-74.4%
NewEMAGIN CORP NEWput$149,0001,172
+100.0%
0.02%
New9 METERS BIOPHARMAput$145,0001,773
+100.0%
0.02%
NewNABRIVA THERAPEUTICS PLC$143,000268,109
+100.0%
0.02%
NewCORDMEDIX INCcall$142,000236
+100.0%
0.02%
NewCURIS INCcall$132,0001,131
+100.0%
0.02%
NewLIPOCINE INC NEWcall$133,000941
+100.0%
0.02%
NewADAMIS PHARMACEUTICALS CORPput$122,0001,565
+100.0%
0.02%
SellBAUDAX BIO INCput$114,000
-40.0%
410
-10.7%
0.02%
-55.3%
EVOK NewEVOKE PHARMA INC$105,00022,382
+100.0%
0.02%
CTXR NewCITIUS PHARMACEUTICALS$92,00088,711
+100.0%
0.01%
BIOL NewBIOLASE INC$92,000333,458
+100.0%
0.01%
MDGSW SellMEDIGUS LTD*w$93,000
-24.4%
544,940
-7.0%
0.01%
-44.0%
BuyLM FUNDING AMERICA INC$97,000
+185.3%
147,304
+489.2%
0.01%
+100.0%
 ENERGY FOCUSput$82,000
-1.2%
1200.0%0.01%
-29.4%
BNTC  BENITEC BIOPHARMA INC$75,000
-20.2%
11,8630.0%0.01%
-42.1%
NSPR BuyINSPIREMD INC$77,000
+250.0%
243,900
+405.0%
0.01%
+175.0%
NewCORDMEDIX INCput$66,000109
+100.0%
0.01%
NewNABRIVA THERAPEUTICS PLCput$51,000958
+100.0%
0.01%
NewZOMEDICA PHARMACEUTICALS$52,000470,548
+100.0%
0.01%
BKYI NewBIO KEY INTL INC$44,000100,000
+100.0%
0.01%
CJJD  CHINA JO JO DRUGSTORES$48,000
-30.4%
50,0000.0%0.01%
-50.0%
 TRANSENTERIX INCput$28,000
-34.9%
7940.0%0.00%
-55.6%
BuyPARETEUM CORPput$20,000
+66.7%
299
+57.4%
0.00%
+50.0%
BuyLIPOCINE INC NEWput$21,000
+61.5%
150
+50.0%
0.00%0.0%
RWLK ExitREWALK ROBOTICS LTD$0-19,082
-100.0%
-0.01%
TEUM ExitPARETEUM CORP$0-56,757
-100.0%
-0.01%
ExitCELSION CORPput$0-145
-100.0%
-0.01%
ENLV ExitENLIVEX THERAPEUTICS LTD$0-12,925
-100.0%
-0.01%
MARK ExitREMARK HOLDINGS INC$0-33,953
-100.0%
-0.02%
ExitREMARK HOLDINGS INCput$0-413
-100.0%
-0.02%
HOTH ExitHOTH THERAPEUTICS INC$0-68,681
-100.0%
-0.04%
ExitALTIMMUNE INCcall$0-189
-100.0%
-0.04%
BPTH ExitBIO PATH HLDGS INC$0-45,000
-100.0%
-0.05%
XBI ExitSPDR SERIES TRUSTetf$0-2,150
-100.0%
-0.05%
ExitCELSION CORPcall$0-653
-100.0%
-0.05%
AIKI ExitAIKIDO PHARMA INC$0-342,121
-100.0%
-0.06%
ExitORAMED PHARMS INCput$0-949
-100.0%
-0.07%
ATNM ExitACTINIUM PHARMACEUTICALS$0-972,285
-100.0%
-0.07%
ExitPREDICTIVE ONCOLOGY INC$0-223,540
-100.0%
-0.07%
GNPX ExitGENPREX INC$0-118,584
-100.0%
-0.08%
ExitTRILLIUM THERAPEUTICSput$0-527
-100.0%
-0.09%
YTRA ExitYATRA ONLINE INC$0-650,000
-100.0%
-0.09%
IMUX ExitIMMUNIC INC$0-53,009
-100.0%
-0.13%
AVGR ExitAVINGER INC$0-2,183,464
-100.0%
-0.14%
MBIO ExitMUSTANG BIO INC$0-234,778
-100.0%
-0.15%
SOLY ExitSOLITON INC$0-102,891
-100.0%
-0.16%
ExitODONATE THERAPEUTICS INCcall$0-223
-100.0%
-0.19%
CLDX ExitCELLDEX THERAPEUTICS INC$0-73,094
-100.0%
-0.19%
NKLAW ExitNIKOLA CORP*w$0-34,500
-100.0%
-0.23%
GLBS ExitGLOBUS MARITIME LTD$0-4,776,735
-100.0%
-0.26%
ExitAVEO PHARMACEUTICALS INCcall$0-4,255
-100.0%
-0.44%
ExitNIKOLA CORPput$0-345
-100.0%
-0.47%
ALNA ExitALLENA PHARMACEUTICALS$0-1,531,446
-100.0%
-0.49%
PLL ExitPIEDMONT LITHIUM LTD$0-498,259
-100.0%
-0.58%
XERS ExitXERIS PHARMACEUTICALS$0-1,086,031
-100.0%
-0.58%
ExitSORRENTO THERAPEUTICS INCcall$0-5,155
-100.0%
-0.65%
ExitSPDR GOLD TRUSTput$0-215
-100.0%
-0.72%
ExitINOVIO PHARMACEUTICALScall$0-2,494
-100.0%
-1.35%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPDR S&P 500 ETF TRUST UNIT37Q3 202349.1%
ISHARES TR35Q3 202352.2%
SPDR S&P BIOTECHNOLOGY32Q3 202212.8%
AMARIN CORP PLC30Q4 20212.0%
BIOGEN INC24Q1 202126.2%
SAREPTA THERAPEUTICS INC24Q3 20204.6%
BIOGEN INC23Q1 202113.7%
SAREPTA THERAPEUTICS INC22Q3 20206.2%
BRAINSTORM CELL THERAPEUTICS INC21Q3 20231.6%
VERTEX PHARMACEUTICALS INC20Q1 201812.6%

View SABBY MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SABBY MANAGEMENT, LLC Q3 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AGM GROUP HOLDINGS, INC.January 10, 2023627,9362.6%
Bit Digital, IncJanuary 10, 20233,166,9173.8%
Cingulate Inc.January 10, 2023105.0%
Context Therapeutics Inc.January 10, 2023796,7065.0%
HeartBeam, Inc.January 10, 2023271,7883.4%
PharmaCyte Biotech, Inc.January 10, 2023934,4565.0%
Rebus Holdings, Inc.Sold outJanuary 10, 202300.0%
TANTECH HOLDINGS LTDJanuary 10, 202341,5000.6%
Quanergy Systems, Inc.January 04, 2023936,9055.8%
TuanChe LtdJanuary 04, 20232,384,71310.0%

View SABBY MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03

View SABBY MANAGEMENT, LLC's complete filings history.

Compare quarters

Export SABBY MANAGEMENT, LLC's holdings